Jonathan Watanabe, PharmD, PhD, MS | Pain and Addiction Research Center

Regulatory Definitions and Classification of Biosimilar Medications Across the 6 Regions of the World Health Organization: A Scoping Review.

JAMA Health Forum

Watanabe JH, Strand MW, Walvekar M, Alfonso-Cristancho R

Beyond Resistance: Prioritizing Safety in Antimicrobial Stewardship for Older Adults.

The Senior care pharmacist

Chahine EB, Watanabe JH, Dong MT, Andrade RM

Challenges of the Inflation Reduction Act for long-term care pharmacy: Examining impact and policy solutions.

Journal of managed care & specialty pharmacy

Bhardwaj S, Schmutz HW, Watanabe JH, Barthold D

ASHP and ASHP Foundation Pharmacy Forecast 2026: Strategic Planning Guidance for Pharmacy Departments in Hospitals and Health Systems.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists

DiPiro JT, Couldry R, Dopp AL, Kraus T, Vest TA, Chou J, Watanabe JH, Fretland K, Fabian TJ, Gosser R, Blind JE, Blackburn H, Gruenberg K, Merandi J, Cunningham FE, Hoffman JM

Innovations in Pharmacy Training and Sustainable Practice to Advance Patient Care: Proceedings of a Workshop

Association of Baseline Comorbidities With First-Year Adherence to GLP-1 Receptor Agonists in Patients With Diabetes or Obesity: A Retrospective Cohort Study.

The Annals of pharmacotherapy

Mai Z, Kornak J, Dufault SM, Strand MW, Reikes AR, Watanabe JH

Insulin Glargine Utilization and Spending Before and After the First Biosimilar Insulin Glargine: A Real-World Data Study.

Journal of general internal medicine

Watanabe JH, Strand MW, Shen W, Kwon J, Reikes A

Off-label policy through the lens of trazodone usage and spending in the United States.

Health affairs scholar

Kadiyala S, Chenoweth M, Watanabe JH

Trends in Pharmacological Treatment of Patients With New Onset Type 2 Diabetes: Usage Patterns in an Evolving Guideline Landscape.

Journal of diabetes

Hou W, Tuttle KR, Shen W, Reikes A, Watanabe JH

Oral versus subcutaneous semaglutide weight loss outcomes after two years among patients with type 2 diabetes in a real-world database.

Expert review of endocrinology & metabolism

Kwon J, Thiara D, Watanabe JH

ASHP and ASHP Foundation Pharmacy Forecast 2025: Strategic Planning Guidance for Pharmacy Departments in Hospitals and Health Systems.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists

DiPiro JT, Hoffman JM, Tichy E, Shea S, Sanborn M, Hung A, Fox ER, Watanabe JH, Torrise V, Abourjaily P, Cunningham FE, Schweitzer P, Nelson SD, Stump LS, Castro H, Nesbit TW, Scott CM

Examining the impact of Anticholinergic Burden on Hospitalized Older People Receiving Concomitant Cholinesterase inhibitors.

The Senior care pharmacist

Guan J, Noviasky J, Watanabe JH

Regulatory Processes for Rare Disease Drugs in the United States and European Union: Flexibilities and Collaborative Opportunities

Preparing the Future Workforce in Drug Research and Development: Proceedings of a Workshop

Enhancing drug evaluation in diverse populations and older adults: National Academies of Sciences, Engineering, and Medicine considerations.

Journal of the American Geriatrics Society

Watanabe JH

Examining the Impact of the World Health Organization 2022 Guidelines on Evaluation of Biosimilars for Non-Local Comparators in Biosimilar Studies on Middle East and North Africa Member States.

Pharmacy (Basel, Switzerland)

Strand MW, Watanabe JH

Aspirin Use in Older People Highlights the Need for Improved Inclusion of Older People in Clinical Trials.

The Senior care pharmacist

Watanabe JH, Zajac D

Advancing Clinical Research with Pregnant and Lactating Populations: Overcoming Real and Perceived Liability Risks

Association of Pre-Pandemic Telehealth With Emergency Department and Telehealth Usage During the Pandemic.

The Senior care pharmacist

Strand M, Watanabe JH

Considerations on the Weight Loss-Associated Glucagon-like Peptide-1 Receptor Agonists for Older People.

The Senior care pharmacist

Watanabe JH

Trends in glucagon-like peptide 1 receptor agonist use, 2014 to 2022.

Journal of the American Pharmacists Association : JAPhA

Watanabe JH, Kwon J, Nan B, Reikes A

Exploring Concomitant Acetylcholinesterase Inhibitor and Overactive Bladder Anticholinergic Use and Risk of Hospitalization in Medicare and Dual-Eligible Medicare-Medicaid Populations in a Historic Database.

Pharmacy (Basel, Switzerland)

Watanabe JH, Hoang T

Improving Care for Opioid Use Disorder in Nursing Facilities.

The Senior care pharmacist

Watanabe JH

Effectiveness of letermovir for cytomegalovirus prophylaxis in allogeneic hematopoietic stem cell transplant recipients: A global systematic review.

Journal of the American Pharmacists Association : JAPhA

Sepassi A, Saunders IM, Bounthavong M, Taplitz RA, Logan C, Watanabe JH

Research with Pregnant and Lactating Persons: Mitigating Risk and Liability: Proceedings of a Workshop—in Brief

Cost Effectiveness of Letermovir for Cytomegalovirus Prophylaxis Compared with Pre-Emptive Therapy in Allogeneic Hematopoietic Stem Cell Transplant Recipients in the United States.

PharmacoEconomics - open

Sepassi A, Saunders IM, Bounthavong M, Taplitz RA, Logan C, Watanabe JH

The Critical Role of Pharmacists in Treating Older People in the Opioid Crisis.

The Senior care pharmacist

Watanabe JH

Minding the gap and the value of metrics: Count of working pharmacists in the United States.

Journal of the American Pharmacists Association : JAPhA

Hirsch JD, Nguyen MH, Abugazia J, Watanabe JH

Responding to "Senior Care Pharmacists Must Be the Disruptive Force that Reduces Adverse Drug Events in Older People".

The Senior care pharmacist

Khartabil N, Watanabe JH

Federal and State Pharmacy Regulations and Dispensing Barriers to Buprenorphine Access at Retail Pharmacies in the US.

JAMA Health Forum

Qato DM, Watanabe JH, Clark KJ

Methadone Treatment for Opioid Use Disorder: Improving Access Through Regulatory and Legal Change: Proceedings of a Workshop

Senior Care Pharmacists Must Be the Disruptive Force that Reduces Adverse Drug Events in Older People.

The Senior care pharmacist

Watanabe JH

Effects of financial toxicity on prescription drug use and mental well-being in cancer patients.

Exploratory research in clinical and social pharmacy

Chan K, Sepassi A, Saunders IM, Goodman A, Watanabe JH

Examination of Medication Use Patterns by Age Group, Comorbidity, and Month in COVID-19 Positive Patients in a Large Statewide Health System During the Pandemic in 2020.

The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians

Watanabe JH, Kwon J, Nan B, Abeles SR, Mehta SR

Risk of Negative Health Outcomes and High Costs for People With Diabetes and Unmet Psychological Needs in the United States.

Diabetes spectrum : a publication of the American Diabetes Association

Sepassi A, Bounthavong M, Singh RF, Heyman M, Beizai K, Watanabe JH

Envisioning a Transformed Clinical Trials Enterprise for 2030: Proceedings of a Workshop

Transferring Key Success Factors from Ambulatory Care into the Community Pharmacy in the United States.

Pharmacy (Basel, Switzerland)

Luli AJ, Awdishu L, Hirsch JD, Watanabe JH, Bounthavong M, Morello CM

Association of Age and Hospitalization Amongst Those with Underlying High-risk Conditions at COVID-19 Diagnosis in a Large, State-wide Health System.

Journal of general internal medicine

Watanabe JH, Kwon J, Mehta SR

When Can We Trust Real-World Data To Evaluate New Medical Treatments?

Clinical pharmacology and therapeutics

Simon GE, Bindman AB, Dreyer NA, Platt R, Watanabe JH, Horberg M, Hernandez A, Califf RM

When Can We Rely on Real-World Evidence to Evaluate New Medical Treatments?

Clinical pharmacology and therapeutics

Simon GE, Platt R, Watanabe JH, Bindman AB, John London A, Horberg M, Hernandez A, Califf RM

When Can Nonrandomized Studies Support Valid Inference Regarding Effectiveness or Safety of New Medical Treatments?

Clinical pharmacology and therapeutics

Franklin JM, Platt R, Dreyer NA, London AJ, Simon GE, Watanabe JH, Horberg M, Hernandez A, Califf RM

Medication Use Patterns in Hospitalized Patients With COVID-19 in California During the Pandemic.

JAMA network open

Watanabe JH, Kwon J, Nan B, Abeles SR, Jia S, Mehta SR

When Are Treatment Blinding and Treatment Standardization Necessary in Real-World Clinical Trials?

Clinical pharmacology and therapeutics

Watanabe JH, Simon GE, Horberg M, Platt R, Hernandez A, Califf RM

DISCARDED MEDICATIONS IN VIALS ARE A SYMPTOM OF OUR HEALTH CARE SYSTEM: A CALL TO ACTION.

Journal of managed care & specialty pharmacy

Watanabe JH, Lieu T, Shortliffe EH

Medications in Single-Dose Vials: Implications of Discarded Drugs

Associations of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use with Colorectal Cancer Risk in the Women's Health Initiative.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Brasky TM, Flores KF, Larson JC, Newton AM, Shadyab AH, Watanabe JH, Lane DS, Thomson CA, LaCroix AZ

Comparison of botulinum toxins for treatment of movement disorders: real-world utilization and cost analysis in a national Medicare population.

Journal of managed care & specialty pharmacy

Kazerooni R, Watanabe JH

Drug Research and Development for Adults Across the Older Age Span: Proceedings of a Workshop

Pharmacist-directed care to optimize medication use: a healthcare imperative in the United States.

Expert review of pharmacoeconomics & outcomes research

Watanabe JH

Association of combination opioid, benzodiazepine, and muscle relaxant usage with emergency department visits in a nationwide cohort in the United States.

International journal of clinical pharmacy

Watanabe JH, Yang J

Pharmacists on the front-line of solving a public health crisis: Increasing access to medications for opioid use disorder.

Journal of the American Pharmacists Association : JAPhA

Luli AJ, Bounthavong M, Watanabe JH

Hospitalization and Combined Use of Opioids, Benzodiazepines, and Muscle Relaxants in the United States.

Hospital pharmacy

Watanabe JH, Yang J

Advancing Pharmacist Collaborative Care within Academic Health Systems.

Pharmacy (Basel, Switzerland)

Awdishu L, Singh RF, Saunders I, Yam FK, Hirsch JD, Lorentz S, Atayee RS, Ma JD, Tsunoda SM, Namba J, Mnatzaganian CL, Painter NA, Watanabe JH, Lee KC, Daniels CD, Morello CM